Department of Neurology, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, USA.
Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
J Alzheimers Dis. 2022;88(1):191-205. doi: 10.3233/JAD-220106.
Substantial evidence from recent research suggests an influential and underappreciated force in Alzheimer's disease (AD) pathogenesis: the pathological signals originate from outside the brain. Pathogenic bacteria produce amyloid-like proteins "curli" that form biofilms and show functional similarities to human amyloid-β (Aβ). These proteins may contribute to neurological disease progression via signaling cascade from the gut to the brain.
We propose that curli causes neuroendocrine activation from the gut to brain that promotes central Aβ pathology.
PGP9.5 and TLR2 levels in response to curli in the lumen of Tg2576 AD mice were analyzed by immunohistochemical and qRT-PCR analysis. Western blot and human 3D in vitro enteroids culture systems were also used. 16S rRNA gene sequencing was used to investigate bacterial dysbiosis.
We found significant increase in bacterial-amyloid curli with elevated TLR2 at the mRNA level in the pre- and symptomatic Tg-AD gut compared to littermate WT controls. This data associates with increased gram-positive bacterial colonization in the ileum of the symptomatic AD mice. We found fundamental evidence for vagus nerve activation in response to bacterial curli. Neuroendocrine marker PGP9.5 was significantly elevated in the gut epithelium of symptomatic AD mice, and this was colocalized with increased TLR2 expression. Enteroids, 3D-human ileal mini-gut monolayer in vitro model system also revealed increase levels of TLR2 upon stimulation with purified bacterial curli fibrils.
These findings reveal the importance of pathological changes within the gut-vagus-brain signaling in response to luminal bacterial amyloid that might play a vital role in central Aβ pathogenesis seen in the AD brain.
最近的研究有大量证据表明,阿尔茨海默病(AD)发病机制中存在一种有影响力但未被充分认识的力量:病理性信号源自大脑之外。致病性细菌产生类似于淀粉样蛋白的“卷曲”蛋白,这些蛋白形成生物膜,并显示出与人淀粉样蛋白-β(Aβ)的功能相似性。这些蛋白质可能通过从肠道到大脑的信号级联反应促进神经退行性疾病的进展。
我们提出卷曲蛋白引起肠道到大脑的神经内分泌激活,从而促进中枢 Aβ病理学。
通过免疫组织化学和 qRT-PCR 分析检测 Tg2576 AD 小鼠肠道腔中卷曲蛋白的 PGP9.5 和 TLR2 水平。还使用了 Western blot 和人 3D 体外肠类器官培养系统。16S rRNA 基因测序用于研究细菌失调。
我们发现与 WT 对照相比,在有症状的 AD 小鼠肠道的预症状和症状期,细菌-淀粉样蛋白卷曲蛋白的水平显著增加,TLR2 在 mRNA 水平上也升高。该数据与症状性 AD 小鼠回肠中革兰氏阳性细菌定植增加相关。我们发现了对细菌卷曲蛋白反应的迷走神经激活的基本证据。在有症状的 AD 小鼠的肠道上皮中,神经内分泌标志物 PGP9.5 显著升高,并且与 TLR2 表达增加相关。3D 人回肠单层迷你肠道体外模型系统也显示,纯化的细菌卷曲原纤维刺激后 TLR2 水平升高。
这些发现揭示了肠道-迷走神经-大脑信号对肠道腔中细菌淀粉样蛋白的病理变化的重要性,这可能在 AD 大脑中所见的中枢 Aβ发病机制中发挥重要作用。